DD159328A5 - Verfahren zur herstellung von parasubstituiertten 3-phenoxy-1-alkylaminopropanolen-2 - Google Patents

Verfahren zur herstellung von parasubstituiertten 3-phenoxy-1-alkylaminopropanolen-2 Download PDF

Info

Publication number
DD159328A5
DD159328A5 DD81230463A DD23046381A DD159328A5 DD 159328 A5 DD159328 A5 DD 159328A5 DD 81230463 A DD81230463 A DD 81230463A DD 23046381 A DD23046381 A DD 23046381A DD 159328 A5 DD159328 A5 DD 159328A5
Authority
DD
German Democratic Republic
Prior art keywords
hydroxy
group
isopropylaminopropoxy
compound
propanoate
Prior art date
Application number
DD81230463A
Other languages
German (de)
English (en)
Inventor
Enar I Carlsson
Bill B R Gustafsson
Bo T Lundgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DD159328A5 publication Critical patent/DD159328A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
DD81230463A 1980-06-02 1981-06-01 Verfahren zur herstellung von parasubstituiertten 3-phenoxy-1-alkylaminopropanolen-2 DD159328A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8004087A SE8004087L (sv) 1980-06-02 1980-06-02 Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...

Publications (1)

Publication Number Publication Date
DD159328A5 true DD159328A5 (de) 1983-03-02

Family

ID=20341101

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81230463A DD159328A5 (de) 1980-06-02 1981-06-01 Verfahren zur herstellung von parasubstituiertten 3-phenoxy-1-alkylaminopropanolen-2

Country Status (25)

Country Link
EP (1) EP0041491B1 (es)
JP (1) JPS5724335A (es)
KR (1) KR850000869B1 (es)
AT (1) ATE11529T1 (es)
AU (1) AU548290B2 (es)
CS (1) CS241484B2 (es)
DD (1) DD159328A5 (es)
DE (1) DE3168595D1 (es)
DK (1) DK154208C (es)
ES (1) ES8300679A1 (es)
FI (1) FI71725C (es)
GR (1) GR74571B (es)
HU (1) HU184860B (es)
IE (1) IE53801B1 (es)
LU (2) LU88317I2 (es)
MY (1) MY8600219A (es)
NL (1) NL930102I2 (es)
NO (1) NO151282C (es)
NZ (1) NZ197237A (es)
PH (1) PH16135A (es)
PL (1) PL135823B1 (es)
PT (1) PT73111B (es)
SE (1) SE8004087L (es)
SU (1) SU1156592A3 (es)
ZA (1) ZA812981B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
JPH08799B2 (ja) * 1984-03-14 1996-01-10 ボ−ダ−，ニコラス・エス 緩和β−アドレナリン遮断薬
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
US4829086A (en) * 1984-03-14 1989-05-09 Bodor Nicholas S Soft β-adrenergic blocking agents
DE3584560D1 (de) * 1984-04-09 1991-12-05 Du Pont Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
JP2521317B2 (ja) * 1986-09-02 1996-08-07 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー ｄｌ―メチル３―［４―（２―ヒドロキシ―３―イソプロピルアミノ）プロポキシ］フエニルプロピオネ―ト［（ｄｌ―エスモロ―ル）］の分割
US5274002A (en) * 1987-04-14 1993-12-28 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
CA2015730C (en) * 1989-05-12 1997-10-07 Sadahiko Iguchi Esters of phenylalkanoic acid
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
EP3101303A4 (en) * 2014-01-29 2017-10-11 Sumitomo Bakelite Co.,Ltd. Brake pad and caliper device
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB673413A (en) * 1950-03-22 1952-06-04 Rhone Poulenc Sa New local anaesthetics which are substituted benzoic esters and processes for making the same
CH512427A (de) * 1967-12-18 1971-09-15 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen racemischen oder optisch aktiven 1-Phenoxy-2-hydroxy-3-sec. -alkylaminopropanen
GB1285038A (en) 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
SE354851B (es) * 1970-02-18 1973-03-26 Haessle Ab
FR2132570B1 (es) 1971-04-09 1974-08-02 Lipha
PT66890B (fr) * 1976-08-21 1979-01-25 Hexachimie Procede pour la preparation des aryloxy-1 amino-3 propanol-2

Also Published As

Publication number Publication date
ZA812981B (en) 1982-05-26
FI71725B (fi) 1986-10-31
GR74571B (es) 1984-06-29
KR850000869B1 (ko) 1985-06-22
NZ197237A (en) 1985-01-31
ES502656A0 (es) 1982-11-01
JPS639501B2 (es) 1988-02-29
IE53801B1 (en) 1989-03-01
ATE11529T1 (de) 1985-02-15
DE3168595D1 (en) 1985-03-14
NL930102I1 (nl) 1993-10-01
PL135823B1 (en) 1985-12-31
NO811799L (no) 1981-12-03
NO151282C (no) 1985-03-13
PT73111B (en) 1983-05-11
PH16135A (en) 1983-07-08
LU88317I2 (fr) 1994-05-04
NO151282B (no) 1984-12-03
CS404781A2 (en) 1985-06-13
ES8300679A1 (es) 1982-11-01
MY8600219A (en) 1986-12-31
AU548290B2 (en) 1985-12-05
NL930102I2 (nl) 1994-12-01
CS241484B2 (en) 1986-03-13
PL231450A1 (en) 1983-03-28
EP0041491B1 (en) 1985-01-30
LU88348I2 (fr) 1994-09-09
EP0041491A1 (en) 1981-12-09
DK154208C (da) 1989-03-20
KR830006177A (ko) 1983-09-20
DK154208B (da) 1988-10-24
FI811671L (fi) 1981-12-03
SU1156592A3 (ru) 1985-05-15
AU7116681A (en) 1982-12-02
FI71725C (fi) 1987-02-09
IE811217L (en) 1981-12-02
DK239581A (da) 1981-12-03
PT73111A (en) 1981-07-01
JPS5724335A (en) 1982-02-08
HU184860B (en) 1984-10-29
SE8004087L (sv) 1981-12-03

Similar Documents

Publication Publication Date Title
DD159328A5 (de) Verfahren zur herstellung von parasubstituiertten 3-phenoxy-1-alkylaminopropanolen-2
DE1493536B1 (de) Neue gamma-Amino-beta-phenyl-buttersaeuren
DD144762A5 (de) Verfahren zur herstellung von phenethanolaminen
DE2332837C2 (de) Amine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE19636689A1 (de) Neue Benzamidinderivate
EP0073505A1 (de) Neue Benzo-Heterocyclen
DD159329A5 (de) Verfahren zur herstellung von substituierten 3-phenoxy-1-alkoxycarbonylalkylaminopropanolen-2
DE2316727C3 (de) o,p-Disubstituierte 3-Phenoxy-lalkylamino-propan-2-ole, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE2317710A1 (de) Dopaminderivate
DD201305A5 (de) Verfahren zur herstellung von in 7-stellung substituierten benzopyranen
CH626047A5 (es)
CH618417A5 (en) Process for the preparation of novel hydroxyamines
DE2458624C3 (de) Phenoxypropylaminderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
CH385196A (de) Verfahren zur Herstellung analeptisch wirksamer N-substituierter Aminonorcamphanderivate
DD208799A5 (de) Verfahren zur herstellung von 3-phenoxy-1-carbonylaminoalkyl-aminopropanol-2-en
DE2362535C2 (de) 2-Amino-1,2,3,4-tetrahydronaphthalin-und 3-Aminochromanol-(4)-Verbindungen und Verfahren zu deren Herstellung
CH637108A5 (en) Process for preparing novel 1-aryloxy-2-hydroxy-3-aminopropanes
CH618416A5 (en) Process for the preparation of novel hydroxyamines
DE3014738C2 (es)
DE2821584A1 (de) Neue, pharmazeutisch wirksame verbindungen, verfahren zu ihrer herstellung und arzneimittel
AT371101B (de) Verfahren zur herstellung neuer optisch aktiver phenethanolamine und der pharmazeutisch unbedenklichen salze hiervon
EP0029992A1 (de) Neue Aminopropanolderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT367742B (de) Verfahren zur herstellung von neuen substituierten 3-(3'-amino-2'-hydroxypropoxyphenyl)-acrylsaeure derivaten sowie deren saeureadditionssalzen
CH645373A5 (de) 2-hydroxy-5-(1-hydroxy-2-(4-(2-oxo-1-benzimidazolinyl)-piperidino)ethyl)benzoesaeure-derivate sowie verfahren zu deren herstellung.
DD202148A5 (de) Verfahren zur herstellung von phenylperhydroazepinen

Legal Events

Date Code Title Description
NPI Change in the person, name or address of the patentee (addendum to changes before extension act)
NPI Change in the person, name or address of the patentee (addendum to changes before extension act)
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
RPI Change in the person, name or address of the patentee (searches according to art. 11 and 12 extension act)
ENJ Ceased due to non-payment of renewal fee